2025
SJR Q1
JCR Q1 · 8,5
12 matched articles
SCIE
Journal detail
International Journal of Molecular Medicine
- Publisher
- Spandidos Publications
- Country
- Greece · Western Europe
- Type
- journal
- ISSN
-
110737561791244X
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,622
- Quartile Q1
- H-Index 124
- Cites/doc 6,76
- Docs (3y) 372
- Cites (3y) 2.512
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 8,5
- 5Y JIF 6,2
- JCI 1,26
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Genetics Q1
- Medicine (miscellaneous) Q1
Areas
- Biochemistry, Genetics and Molecular Biology
- Medicine
WoS categories
- Medicine, Research & Experimental
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 1,622 | 8,5 | 6,2 | 1,26 | Q1 | 124 |
| 2024 | Q1 | Q1 | 1,381 | 5,8 | 4,9 | 1,21 | Q1 | 117 |
| 2023 | Q1 | Q1 | 1,167 | 5,7 | 4,4 | 1,14 | Q1 | 117 |
| 2022 | Q1 | Q2 | 1,029 | 5,4 | 4,8 | 1,14 | Q1 | 117 |
| 2021 | Q1 | Q2 | 0,922 | 5,3 | 4,9 | 1,06 | Q1 | 117 |
| 2020 | Q1 | Q2 | 1,048 | 4,1 | 4,1 | 1,09 | Q1 | 117 |
| 2019 | Q1 | Q3 | 0,882 | 3,1 | 3,1 | 1,12 | Q1 | 117 |
| 2018 | — | Q2 | — | 2,9 | 2,8 | 1,09 | Q1 | — |
| 2017 | Q1 | Q2 | 0,992 | 2,8 | 2,6 | 1,02 | Q2 | 117 |
| 2016 | Q1 | Q3 | 0,97 | 2,3 | 2,3 | — | — | 117 |
| 2015 | Q1 | Q3 | 0,891 | 2,3 | 2,1 | — | — | 117 |
| 2014 | Q1 | Q3 | 0,873 | 2,1 | 2 | — | — | 117 |
| 2013 | Q2 | Q3 | 0,791 | 1,9 | 1,9 | — | — | 117 |
| 2012 | Q2 | Q3 | 0,764 | 2 | 2 | — | — | 117 |
| 2011 | Q2 | Q3 | 0,694 | 1,6 | 1,7 | — | — | 117 |
| 2010 | Q1 | Q3 | 0,791 | 1,8 | 1,8 | — | — | 117 |
| 2009 | — | Q3 | — | 2 | 1,7 | — | — | — |
| 2008 | — | Q3 | — | 1,9 | 1,7 | — | — | — |
| 2007 | — | Q2 | — | 1,8 | 1,7 | — | — | — |
| 2006 | — | Q2 | — | 1,9 | — | — | — | — |
| 2005 | — | Q2 | — | 2,1 | — | — | — | — |
| 2004 | — | Q1 | — | 3,2 | — | — | — | — |
| 2003 | — | Q2 | — | 1,9 | — | — | — | — |
| 2002 | — | Q2 | — | 2,1 | — | — | — | — |
| 2001 | — | Q2 | — | 1,7 | — | — | — | — |
| 2000 | — | Q2 | — | 1,9 | — | — | — | — |
| 1999 | — | Q3 | — | 1,1 | — | — | — | — |
| 1998 | — | Q4 | — | — | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | Q1 | 22/191 |
| 2024 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | Q1 | 39/195 |
| 2023 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | Q1 | 32/189 |
| 2022 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q1 | 43/136 |
| 2021 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q1 | 53/139 |
| 2020 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q1 | 68/140 |
| 2019 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q1 | 71/139 |
| 2018 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q1 | 65/136 |
| 2017 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 65/133 |
| 2016 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 73/128 |
| 2015 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 63/124 |
| 2014 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 70/123 |
| 2013 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 77/124 |
| 2012 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 73/121 |
| 2011 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 72/112 |
| 2010 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 57/106 |
| 2009 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 52/93 |
| 2008 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 49/83 |
| 2007 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 40/81 |
| 2006 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 34/76 |
| 2005 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 33/72 |
| 2004 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 16/71 |
| 2003 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 33/72 |
| 2002 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 25/74 |
| 2001 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 31/75 |
| 2000 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 27/74 |
| 1999 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 41/76 |
| 1998 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 70/72 |